Global clinical trial recruitment industrydata book is a collection of market sizing information & forecasts, legal authorizations, payout/reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Clinical Trial Patient Recruitment Market Analysis & Forecast The global patient recruitment market generated over USD 780 million revenue in 2021 and is projected to expand at a CAGR of around 8.0% during the forecast period. The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market. However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient’s visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials. However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021. Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market. With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners. Access the Global Clinical Trial Recruitment Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Clinical Trial Site Management Organization Market Analysis & Forecast The global clinical trials site management organizations market size was valued at USD 4,792.5 million in 2021 and is anticipated to expand at a CAGR of 5.8% from 2022 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the burden associated with clinical research. SMOs offer several services including patient enrollment services, addressing clinical trial location-specific study activities, hiring study staff, and monitoring clinical studies site operations. Improved technological use in integrated site networks and clinical trial services, increasing trend of outsourced clinical services, and growing clinical trial activities globally owing to the high burden of chronic and infectious diseases, are few of the factors driving the market. Technology has improved efficiencies at the site level by improving metrics such as on-site identification, selection, and performance, as well as throughout the patient spectrum by analyzing recruitment, enrollment, selection, retention, and compliance measures at sites. Furthermore, technical improvements have resulted in enhanced biostatistics and data analytics analysis to better evaluate a drug's feasibility early in the development phase. As a result of the COVID-19 pandemic, several organizations were forced to halt operations while others were forced to completely shut down. However, the SMOs execute multi-eccentric trials effectively to save the firm money and time. Manual processes and paperwork are replaced by digital technologies to limit the negative impact of the pandemic on the business. Due to this, Site Management Organization facilitates detailed documentation while also streamlining the procedure in any clinical research, even when physical contact is nearly impossible to prevent viral spread. SMO's efficient follow-up skills along with the adoption of virtual technologies to conduct clinical research have significantly decreased the time required to recruit patients. As new virus strains are being discovered in different areas of the world, research would remain a top focus. SMOs would be required by health and biotech companies for data collection, participant or patient safety, patient recruitment, more accurate doctor contact information, and other tasks. Hence, such factors are supporting the rebound of revenues across the market during 2021. Clinical Trial Support Services Market Analysis & Forecast The global clinical trials support services market was valued at USD 10,124 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain to a severe extent in 2020. However, it also revealed ways to grow, either through M&A or through the adoption of digital technologies in clinical research. Clinical trials encounter some concerning statistics, such as 85% of the clinical trials fail to recruit enough participants, 80% are delayed due to recruiting challenges, and the rate of dropout of participants is increasing. However, to overcome this, a patient retention strategy that is engaging and gives clarity is required. It is critical to ensure that the informed consent materials are simple to grasp. According to a CISCRP study, 35% of trial participants who later dropped out stated that informed consent was difficult to comprehend. An average American is 7th to 8th grade educated, and it is critical to guarantee and analyze the material’s readability before submitting it to the Institutional Review Board (IRB). Adoption of virtual clinical trials across the clinical trials support services industry is one of the major factors that has boosted revenue growth post-pandemic. An increasing number of clinical research organizations are focusing on the adoption of virtual technologies to streamline their clinical research services. According to the latest Annual CRO Report by the Veeva Unified Clinical Operations Survey, CROs are making significant advancements to speed up and modernize clinical trials. Findings from Veeva Systems reflect that CROs have taken decisive action to streamline trial execution by adopting new technologies and digital strategies that replace manual processes, eradicate information siloes, and enable trial collaborations. Order Free Sample Copy of Clinical Trial Recruitment Industry Data Book, published by Grand View Research Key players operating in the clinical trial recruitment industry are – • Antidote • Clara Health • Clariness • BBK Worldwide • Worldwide Clinical Trials • Clinical Site Services (CCSi) • IQVIA • PPD Inc • Veristat • Elligo Health Research • Charles River Laboratories Inc. • Eurofins Scientific SE • Syneos Health Inc. • The Pharmaceutical Product Development LLC • Icon PLC • WuXi AppTec • LabCorp • Alcura • Parexel International • Clinedge • WCG • ClinChoice • Access Clinical Research • FOMAT Medical Research INC. • SGS • KV Clinical • SMO-Pharmina • Xylem Clinical Research • Aurum Clinical Research
0 Comments
Global male infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book. Male Infertility Diagnosis Market Analysis & Forecast The global male infertility diagnosis market size was valued at USD 343.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.89% from 2023 to 2030. A study published in the Journal of Urology in 2020 mentioned that the prevalence of male infertility in the U.S. was around 15%. This can be attributed to the increase in consumption of alcohol, smoking, obesity, stress, and lifestyle changes. Studies have shown that smoking can damage sperm DNA, reduce sperm motility & count, and increase the percentage of abnormal sperm. It can also lead to erectile dysfunction and decreased libido. Smoking can also affect the success rate of ARTs, such as IVF. Thus, as a result of the abovementioned factors, the increasing incidence of infertility is expected to help the market grow. Microscopic examination is an important diagnostic test for male infertility. It involves the analysis of a semen sample under a microscope to evaluate the quantity, quality, and motility of sperm. The test can help identify issues such as low sperm count, poor sperm motility, and abnormal sperm morphology. Based on diagnosis techniques, DNA fragmentation test accounted for the largest share of 21.76% of the diagnosis market in 2022, due to its ability to provide reliable analysis of sperm DNA integrity. It is also expected to exhibit the strongest growth during the forecast period. The manual method is still widely used for semen analysis in developing economies. However, this method is expected to be replaced by computer-assisted semen analysis in the coming years. Access the Global Male Infertility Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Male Infertility Treatment Market Analysis & Forecast The global male infertility treatment market is valued at USD 3.68 billion as of 2022 and is expected to expand at a CAGR of 4.86% for the forecast period 2023-2030. High adoption of Assisted Reproductive Technology (ART) is a significant driver for the male infertility market. The increasing awareness and acceptance of ART have led to a surge in demand for these procedures. According to a report by the Centers for Disease Control and Prevention (CDC), the use of ART has doubled in the past decade in the U.S. alone. In 2022, ART dominated the market with a revenue share of 71.11% and is likely to maintain its lead during the forecast period. Drugs and hormonal therapy are preferred for initial treatment. ART is usually preferred in case treatment with medication fails. Furthermore, advancements in technology and techniques have significantly improved the success rate of ART procedures. For instance, the use of Preimplantation Genetic Testing (PGT) has resulted in higher success rates of IVF procedures by helping identify chromosomally normal embryos. Hence, as a result of the aforementioned factors, the male infertility market may grow over the forecast period. Male Infertility Market – Global Industry Segmentation Male Infertility Diagnosis Market (Revenue, USD Million, 2018 - 2030) • Technique • DNA Fragmentation Technique • Oxidative Stress Analysis • Microscopic Examination • Sperm Agglutination • Computer Assisted Semen Analysis • Sperm Penetration Assay • Others Male Infertility Treatment Market (Revenue, USD Million, 2018 - 2030) • Type • ART and varicocele surgery • Medication Male Infertility Industry, By Region (Revenue, USD Million, 2018 - 2030) • North America o U.S. o Canada • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o China o India o Japan o Australia o Thailand o South Korea • Latin America o Brazil o Mexico o Argentina • MEA o South Africa o Saudi Arabia o UAE o Kuwait Order Free Sample Copy of Male Infertility Industry Data Book, published by Grand View Research Key players operating in the male infertility industry are – • EMD Serono, Inc. • Endo International plc • Sanofi • Bayer Group • SCSA Diagnostics • Halotech DNA SL • Intas Pharmaceuticals Ltd. • Aytu BioScience, Inc. • Cadila Pharmaceuticals • Vitrolife Surgical Robots Industry Data Book Covers Orthopedics and Non- Orthopedics Market. The global surgical robots market was valued at USD 3.5 Billion in 2022 and is anticipated to grow at a CAGR of 18.0 % over the forecast period. Global surgical robots industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a surgical robots statistics e-book. Access the Global Surgical Robots Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Orthopedics Market Analysis & Forecast The global orthopedics market was valued at USD 805.7 million in 2022 and is anticipated to grow at a CAGR of 12.8% over the forecast period. The growth is attributed to the increasing prevalence of orthopedic conditions, such as degenerative bone disease, the growing geriatric population, and an increasing number of accidents. According to a study conducted by WHO, around 80% of the geriatric population lives in middle and low-income nations. This is anticipated to create a huge opportunity for key players in the market to expand their presence in emerging nations. Moreover, the early onset of musculoskeletal problems, mostly caused by a sedentary lifestyle and obesity, is expected to drive market expansion. Musculoskeletal diseases affect around 1.71 billion people globally, according to the Global Burden of Disease in 2021. As a result, an increase in musculoskeletal problems is expected to drive the market over the forecast period. Additionally, growing awareness regarding the availability of innovative items is causing hospitals to improve their technology and services frequently. Furthermore, payment coverage for orthopedic therapies has contributed to the adoption of orthopedic procedures. Prominent players in the market are adopting strategies such as acquisitions, collaborations, new product launches, and expansions to strengthen their market position. For instance, in May 2023, Zimmer Biomet Holdings, Inc. announced the acquisition of OSSIS, a medical company specializing in customized 3D-printed implants and complex hip replacements. This acquisition is expected to enhance Zimmer Biomet’s capabilities in providing technologically advanced personalized orthopedic solutions. Non-Orthopedics Market Analysis & Forecast Non-Orthopedic applications of surgical robots include robots for neurology, cardiology, gynecology, urology, and others. The global non-orthopedic market was valued at USD 2.74 billion in 2022 and is anticipated to grow at a CAGR of 19.2% over the forecast period. The growth is attributed to the increasing prevalence of neurological disorders coupled with the rising number of road accidents causing brain injuries. According to the International Brain Injury Association, around one million traumatic brain injuries are treated in the United States every year. Additionally, around 80,000 patients are discharged from hospitals with traumatic brain injury disability. Furthermore, technological advancements in the field of neurology, urology, and gynecology have eliminated direct human involvement in surgical operations. These devices are reducing the downsides of invasive procedures. Data recorders, HD microscopic cameras, remote navigation systems, motion sensors, transducers, and robotic-controlled catheters are among the most recent advancements. The major market participants are investing much in R&D to develop technologically advanced medical devices. For example, Brain Scientific, Inc. will deliver the next-generation NeuroCap device in March 2021. It is an advanced EEG electrode array that is utilized in clinical and research settings to deliver quick EEGs whenever required. This is anticipated to drive market growth in the coming years. Furthermore, the increasing prevalence of high blood pressure and diabetes is also contributing to the rising demand for efficient and technologically advanced urology solutions. According to data published by the American Kidney Fund, around 25% of kidney failures are caused due to high blood pressure, and around 38.4% of kidney conditions are caused due to diabetes. The aforementioned factor is anticipated to drive the market demand over the forecast period. Moreover, key players in the market are acquiring new players in the market to strengthen their market share and expand to untapped markets. In addition, market players are investing in R&D for the development of technologically advanced solutions. In September 2021, NovaSignal Corp. announced the closing of a USD 31 million Series C1 funding round. The company will use the resources for its commercial expansion, and development of innovative products. Order Free Sample Copy of "Surgical Robots Industry Data Book - Orthopedics and Non- Orthopedics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research Key players operating in the surgical robots industry are – • Stryker • Medrobotics • Smith+Nephew • TransEnterix Surgical, Inc. • Renishaw plc. • Intuitive Surgical • Medtronic • THINK Surgical, Inc. • Zimmer Biomet Global Spectrometry Industry databook is a collection of market sizing & forecast insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. Spectrometry Market Insights The global spectrometry market size was estimated at USD 17.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.34% from 2022 to 2030. The market is expected to expand at a CAGR of 7.2% from 2021 to 2028. Key players offer technologically advanced spectrometry products for several healthcare applications and have collaborated with research institutes to develop novel products. The market is expected to show potential growth in the coming future owing to the introduction of healthcare services using MALDI-TOF mass spectrometry (MS) by key players operating in the market. For instance, in November 2020, Shimadzu Corporation launched the Amyloid MS service for the early diagnosis of amyloid-positive patients in the U.S. The analysis of blood is performed using a combination of MALDI-TOF MS (IP-MS) and immunoprecipitation. Access the Global Spectrometry Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Mass Spectrometry Market Insights The global mass spectrometry market size was valued at USD 5.83 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.87% from 2022 to 2030. Rising awareness regarding early detection of chronic and infectious diseases and emerging technological advancements in diagnostic instruments are expected to significantly drive the market growth. In addition, there has been an increase in demand for cost-effective and automated techniques for disease diagnosis which is anticipated to increase the demand for mass spectrometry techniques and positively affect the growth. The COVID-19 pandemic has boosted the demand for vaccine development due to recent advancements in virology-based research. Here, mass spectrometry has applications for the study of viral structure for SARS-CoV-2. The technique can also be used to study complex protein structures and protein-protein interactions associated with the virus. Hence, various pharmaceutical and biotechnology companies involved in COVID-19 vaccine and drug development efforts are anticipated to increase the demand for instruments and consumables. NMR Spectroscopy Market Insights The global nuclear magnetic resonance spectroscopy market size was valued at USD 657.11 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030. The market is anticipated to expand at a CAGR of 5.1% from 2023 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied. The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW–Madison’s National Magnetic Resonance Facility at Madison. Near-Infrared Spectroscopy Market Insights The global near-infrared spectroscopy market size is expected to reach USD 453.72 million in 2021, registering a CAGR of 6.08% over the forecast period, according to a new report by Grand View Research, Inc. The growing implementation of an analytical technique for raw materials in numerous sectors, such as oil & gas and agriculture, coupled with their increasing applications is anticipated to spur industry growth. For instance, various herbs and plants with therapeutic and medicinal properties are analyzed through near-infrared (NIR) spectroscopy to assess the bio-active components. The industry has witnessed considerable growth in 2021 and is expected to have similar developments during the forecasted period. The demand for the products from the material science sector is a substantial contributor to the revenue. NIR spectrometry provides significant advantages as a process analytical technology over other techniques including wet chemical methods, resulting in increasing preference from manufacturers. Other determinants, such as rapid advancement in the workflows of material verification, as well as improving risk management in the supply chain by manufacturers to fulfill the GMP criteria, are also contributing to the growth. The major 20 pharmaceutical manufacturers employ portable NIR analyzers to authenticate either raw materials or finished products to comply with GMP guidelines. Similarly, regulatory bodies in Europe, North America, Africa, and Asia have purchased the product to strengthen their counterfeiting efforts. Order Free Sample Copy of Spectrometry Industry Data Book, published by Grand View Research In-line UV-vis Spectroscopy Market Insights Notable technological advancements in the UV-vis spectroscopic method have accelerated the in-line monitoring of compounds using UV-vis-spectrometry across various fields, such as environmental monitoring, materials science, pharmaceutical research, and agriculture. The introduction of advanced solutions, such as enhanced silicon and InGaAs detectors & Light-emitting Diode (LED) sources, have supported the adoption of this UV-Vis spectroscopy technique, thereby driving the industry. UV/Visible spectrophotometers are widely used by laboratories, including that associated with academia and governments, as well as other industries. The introduction of multiple regulatory guidelines for effective approval and new product development processes across various industries, such as the pharmaceutical, food & beverages, and cosmetics industries, is anticipated to increase the adoption of products. In the pharmaceutical industry, the introduction of UV-Vis spectrophotometry that operates in compliance with United States Pharmacopeia (USP), Japanese Pharmacopoeia (JP), and the European Pharmacopoeia (EP) is anticipated to drive the industry. Key players operating in the spectrometry industry are – • Danaher Corporation • Thermo Fisher Scientific, Inc. • PerkinElmer, Inc. • Agilent Technologies, Inc. • Waters Corporation • Shimadzu Corporation • Bruker Corporation • JEOL Ltd Global endoscopy devices industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with an endoscopy devices statistics e-book. Access the Global Endoscopy Devices Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Endoscopes Market Insights The global endoscopes market was valued at USD 18.8 Billion in 2022 and is anticipated to grow at a CAGR of 9.0% over the forecast period. It is expected to grow at a compound annual growth rate (CAGR) of 9.0% from 2023 to 2030. Growing awareness levelsabout minimally invasive surgical procedures and the increasing prevalence of chronic disorders are the major factors accelerating the market growth. The benefits, such as less surgery-related blood loss, no muscle cutting, and quicker recovery, offered by minimally invasive surgeries boost the adoption of endoscopic procedures over traditional/open-invasive surgeries. In addition, advancement in endoscopic technology and the rapid increase of its application to diagnose and treat various diseases are other key factors anticipated to propel the market growth over the forecast years. The flexible endoscopes product segment dominated the market in 2022. This is attributed to the high demand for these devices on account of their unique features, such as the ability to reach viscera & cavities, better safety & efficiency, and improved ergonomic features. These devices are most commonly used in several endoscopic procedures, such as esophagogastroduodenoscopy (OGD), bronchoscopy, sigmoidoscopy, laryngoscopy, pharyngoscopy, nasopharyngoscopy, rhinoscopy, and colonoscopy procedures, which supports the product demand and segment growth.In 2022, the outpatient facilities end-use segment dominated the market. Increasing adoption of endoscopes across outpatient facilities, such as ambulatory surgery centers (ASCs) and diagnostic clinics, for the early diagnosis and detection of several life-threatening diseases is supporting the segment's growth. Endoscopy Visualization Component Market insights The global endoscopy visualization component market was valued at USD 6.7 Billion in 2022 and is anticipated to grow at a CAGR of 7.0% over the forecast period. Significant increase in the number of endoscopic procedures and increasing preference for minimally invasive surgeries are major factors contributing to the expansion of the market. Owing to the advantages of endoscopy over open surgeries, significant cost savings, and favorable government reimbursement policies, the demand for endoscopy is increasing. This coupled with the rapid adoption of advanced diagnostic tools has created a need for advanced visualization techniques. As a result, various manufacturers are focusing on introducing systems and components with better visualization capabilities. For instance, in September 2020, PENTAX Medical, a division of Hoya Corporation announced the launch of J10 Series Ultrasound Video Gastroscopes that offers renowned image quality and enhanced mobility. The endoscopy visualization systems segment is estimated to dominate the market throughout the forecast period. Endoscopy is being widely used in various medical specialties such as gastroenterology, urology, gynecology, pulmonology, ENT, and others. Rising usage of high definition systems and increasing prevalence of cancer are factors favoring the growth of the segment. According to the WHO, the number of new bladder cancer cases is projected to rise from 573,000 in 2020 to 767,000 by 2030. Furthermore, rising government initiatives for newborns hearing screening are expected to drive the growth of the segment. Order Free Sample Copy of Endoscopy Devices Industry Data Book, published by Grand View Research Endoscopy Visualization System Market Insights The global endoscopy visualization system market was valued at USD 16.7 Billion in 2022 and is anticipated to grow at a CAGR of 6.8% over the forecast period. Significant increase in the number of endoscopic procedures and increasing preference for minimally invasive surgeries are major factors contributing to the expansion of the market. Owing to the advantages of endoscopy over open surgeries, significant cost savings, and favorable government reimbursement policies, the demand for endoscopy is increasing. This coupled with the rapid adoption of advanced diagnostic tools has created a need for advanced visualization techniques. As a result, various manufacturers are focusing on introducing systems and components with better visualization capabilities. For instance, in September 2020, PENTAX Medical, a division of Hoya Corporation announced the launch of J10 Series Ultrasound Video Gastroscopes that offers renowned image quality and enhanced mobility. The endoscopy visualization systems segment is estimated to dominate the market throughout the forecast period. Endoscopy is being widely used in various medical specialties such as gastroenterology, urology, gynecology, pulmonology, ENT, and others. Rising usage of high definition systems and increasing prevalence of cancer are factors favoring the growth of the segment. According to the WHO, the number of new bladder cancer cases is projected to rise from 573,000 in 2020 to 767,000 by 2030. Furthermore, rising government initiatives for newborns hearing screening are expected to drive the growth of the segment. Endoscopy Operative Devices Market Insights The global endoscopy operative devices market was valued at USD 8.6 Billion in 2022 and is anticipated to grow at a CAGR of 5.7% over the forecast period. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The rising prevalence of chronic diseases, surging demand for minimally invasive procedures, and increasing technological advancement in endoscope systems are the key factors aiding the market growth. An increase in the preference for keyhole or minimally invasive surgeries due to shortened hospitalization reduced post-operative complications, and decreased blood loss during surgeries is expected to fuel the market growth. The growing geriatric population burdened with chronic diseases is rapidly increasing across the globe and is a potential consumer base for endoscopes. This is likely to significantly drive the market over the forecast period. The rising prevalence of gastrointestinal, respiratory, urological, and gynecological disorders, wherein endoscope systems are used to diagnose and treat the ailment, is expected to significantly contribute to the market growth. The growing prevalence of cancer and obesity across the globe is expected to drive the demand for endoscopy operative devices. For instance, the introduction of endoscopic bariatric surgeries as preventive measures is contributing to the growing demand. Similarly, laryngoscopy, colonoscopy, and upper endoscopy are used to diagnose lung, colorectal, and breast cancers. In addition, owing to an anticipated increase in demand for diagnostic and surgical procedures, the market is poised to grow at a higher rate from the first quarter of 2021. Go through the table of content of Endoscopy Devices Industry Data Book to get a better understanding of the Coverage & Scope of the study. Endoscopy Devices Industry Data Book Competitive Landscape Increasing demand for endoscopy devices is increasing competition in the market and, thus, forcing key players to introduce new products in the market. Additionally, it is projected that rising industry consolidation activities, such as acquisitions and mergers by the leading market participants, as well as expanding efforts in R&D of endoscopy device applications by key players, are also expected to boost the market share. Key players operating in the endoscopy devices industry are – • Olympus Corporation • Ethicon Endo-surgery, LLC. • FUJIFILM Holdings Corporation • Stryker Corporation • Boston Scientific Corporation • Karl Storz GmbH & Co. KG • Smith & Nephew Inc. • Richard Wolf GmbH • Medtronic Plc (Covidien) • PENTAX Medical • Machida Endoscope Co., Ltd Advanced Wound Dressing Products Industry| Revolutionizing Wound Care | Data Book to 203011/28/2023 Global advanced wound dressing products industry databook, published by Grand View Research’s is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Access the Global Advanced Wound Dressing Products Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Foam Dressings Market Insights The global foam dressings market generated over USD 1.7 Billion revenue in 2022 and is projected to expand at a CAGR of around 4.71% during the forecast period. A few of the key drivers propelling the market growth include an increase in surgical cases, a rapidly aging population, and an increase in the number of diabetes patients. For instance, according to the World Economic Forum, the current population of Japanese people above 65 years of age is 25% of the total population. This number is further expected to rise to 40% by 2060. Older people are more likely to sustain wounds, thus, the market for foam dressing is expected to grow throughout the forecast period. An increase in the number of obese/overweight people is another fueling factor of the market. For instance, according to an article by Sage Journals & Indian Academy of Neurosciences, 2021, the number of obese people in India is estimated to be 135 million. Similarly, as per the Obesity Evidence Hub, two-thirds of the Australian people, i.e., 35.6% are overweight, whereas, 31.3% are expected to be obese. These situations are anticipated to raise demand for bariatric treatments and other related surgeries, driving the growth of the market over the anticipated time frame. Hydrocolloid Dressings Market Insights The global hydrocolloid dressings market generated over USD 1.3 Billion revenue in 2022 and is projected to expand at a CAGR of around 5.01% during the forecast period. Increasing prevalence of chronic and acute wounds, rapidly aging population, rising number of diabetic patients, and surge in research and development activities are among the major factors driving the market growth. The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, among the general population is likely to increase the number of patients getting treatment and fuel the adoption of hydrocolloid dressings. Furthermore, the rising prevalence of acute wounds, such as surgical wounds and burns, is further expected to drive the demand for hydrocolloid wound dressings throughout the projected period. Surgical wounds, for example, are a major problem in general healthcare, according to the Wound Healing Society (WHS). Despite all attempts, Surgical Site Infections (SSI) cause death in 75% of patients globally. As a result, the increased incidence of infections has imposed a significant cost burden on the healthcare business. This is likely to contribute to the launch of advanced products, thus fostering market growth. Clinical uses for several hydrocolloid materials have been proposed in recent years. Film Dressings Market Insights The global film dressings market generated over USD 1.5 Billion revenue in 2022 and is projected to expand at a CAGR of around 4.57% during the forecast period. The film dressing market growth can be accredited to the rising prevalence of chronic wounds, globally. People with diabetic foot ulcers are becoming more common, due to the rise in the population of those with chronic illnesses such as diabetes. For instance, the International Diabetes Federation estimates that 61 million people in Europe between the age of 20 and 79 have diabetes. The incidence rate of diabetic foot ulcers, according to NCBI, ranges from 9.1 million to 26.1 million per year worldwide. Thus, the rise in diabetes and diabetic foot ulcer patients is driving the film dressing market during the forecast period. Additionally, the number of traumatic events such as burns, gunshot wounds, and car accidents has increased, globally. For instance, as per the WHO estimates there are 11.0 million burn cases, worldwide, resulting in 180,000 fatalities every year. Similar to this, more than 30,000 burn cases are reported daily, worldwide, according to NCBI. Therefore, it is projected that the film dressings market would be driven by the rising number of burn cases, worldwide, during the forecast period. Order your copy of the Free Sample of Advanced Wound Dressing Products Industry Data Book, published by Grand View Research Alginate Dressings Market insights The global alginate dressings market generated over USD 902.9 Million revenue in 2022 and is projected to expand at a CAGR of around 4.13% during the forecast period. The market growth is mainly driven by the rising prevalence of chronic & acute wounds globally. For instance, as per a study by the NCBI, the prevalence rate of chronic wounds in the general population was calculated to be 2.21 per 1,000 populations in 2018. Similarly, as per Lippincot Williams & Wilkins Journals, the total prevalence rate of chronic wounds was estimated to be 16.8 per 1,000 hospital inpatients in Northern China. Thereby, impelling the industry growth. In addition, an increase in the number of traumatic accidents, such as road accidents, burn cases, gunshot wounds, etc., across the globe is expected to further boost industry growth. For instance, according to the National Highway Traffic Safety Administration, an estimated 38,680 people died in 2020 as a result of motor vehicle crashes. This was a 7.2% increase from 2019. Moreover, as per American Burn Association, every year around 450,000 burn cases, which require medical attention, are reported in the U.S. alone.Furthermore, the industry is expected to propel post-pandemic due to an increase in the volumes of surgeries post-COVID-19. In addition, industry players are entering into various strategic alliances, such as partnerships, mergers, acquisitions, product launches, and geographic expansion. For instance, Medline Industries invested USD 1.5 billion in strengthening its domestic supply chain to meet the growing demand. These initiatives are expected to help the market grow over the forecast period. Hydrogel Dressings Market Insights The global hydrogel dressings market generated over USD 883.8 Million revenue in 2022 and is projected to expand at a CAGR of around 4.30% during the forecast period. The market growth can be accredited to the rising prevalence of chronic wounds globally. The properties of hydrogel-based dressings can be adjusted much more easily compared to conventional chronic wound therapy methods. Moreover, owing to their adaptability and versatility, hydrogel dressings can be loaded with cells, antibacterial, antiviral, and antifungal agents, growth factors, and biomolecules to hasten wound contraction and healing. Furthermore, their ability to create in situ and cytocompatible chemical crosslinking these dressings may be easily applied to irregular or deep wounds. Thereby, owing to the above-mentioned advantages is expected to impel the hydrogel dressing market. Massive research is being conducted in order to create novel hydrogel products from natural sources such as animal tissues, plant extracts, extracellular matrix, and others. Firms are extensively spending on R&D and are continuously working on achieving positive clinical trial results. For instance, Remedor Biomed Ltd. is conducting clinical studies on a hydrogel containing erythropoietin to treat diabetic foot ulcers. In addition, a variety of peptides are being studied in clinical studies for their wound-healing abilities. Thus, rigorous clinical studies to commercialize novel hydrogel dressing products are expected to drive the growth of the hydrogel dressing market in the near term. Collagen Dressings Market Insights The global collagen dressings market generated over USD 691.7 Million revenue in 2022 and is projected to expand at a CAGR of around 3.77% during the forecast period. This can be attributed primarily to the increase in the number of people suffering from various chronic disorders such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. For instance, according to the Agency for Healthcare Research and Quality, every year, more than 2.5 million U.S. residents suffer from pressure ulcers. These are associated with serious infections; therefore, the use of collagen dressing is expected to increase over the forecast duration. Moreover, a rise in the number of people suffering from leg ulcers may further propel the market growth. For instance, as per NCBI, around 1.5 – 3.0 people in 3,000 have an active leg ulcer at any given point. Similarly, according to the National Health Service, venous leg ulcers are estimated to affect about one in 500 residents in the U.K., thereby boosting the market over the forecast period. Go through the table of content of Advanced Wound Dressing Products Industry Data Book to get a better understanding of the Coverage & Scope of the study. Advanced Wound Dressing Products Industry Data Book Competitive Landscape The market is highly fragmented in nature with the presence of several small and large manufacturers. Competitive rivalry and degree of competition in the wound market is expected to intensify over the forecast period due to the presence of many players in the market. Furthermore, leading players are involved in collaborations, product launches, mergers and acquisitions to strengthen their product portfolios. Key players operating in the advanced wound dressing products industry are – • Smith & Nephew • Molnlycke Health Care AB • ConvaTec Group PLC • Baxter International • URGO Medical • Coloplast Corp. • Medtronic • 3M • Derma Sciences Inc. (Integra LifeSciences) • Medline Industries Global Ultrasound devices and accessories industry databook is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Ultrasound Device Market Insights The global ultrasound device market size was estimated at USD 10.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030. The market is expected to experience steady growth during the forecast period. This is attributed to several factors such as increased adoption of ultrasonography for diagnostic and therapeutic applications, rising technological advancements, as well an increase in the number of product launches by key players operating in the market. Emerging innovations in ultrasound technology are expanding the market size. Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities globally. Furthermore, the introduction of 3D/4D ultrasound and the integration of artificial intelligence (Al) to automate time-consuming processes are expected to propel market growth during the forecast period. For instance, in July 2023, Sonosite ST was introduced by FUJIFILM Sonosite ST. It has a 21-inch touchscreen with an all-touch interface, a 10" by 7.5" image area, automated setting optimization for each exam type, and Auto Steep Needle Profiling (SNP). To support system compatibility, Sonosite ST belongs to the same family of transducers as Sonosite PX and Sonosite LX. The growing use of ultrasound equipment for diagnostic imaging and therapy, as well as the rising prevalence of chronic and lifestyle-related illnesses are the key factors anticipating the market’s growth. Ultrasound technology is used in various application areas such as cardiology, obstetrics/ gynecology, vascular, orthopedic, and general imaging. The rising prevalence of cardiac disorders is expected to boost the market globally. According to WHO, Cardiovascular diseases (CVDs) are the major cause of death globally, taking approximately 17.9 million lives each year. In addition, as per the Centers for Disease Control & Prevention, in the United States, every year about 805,000 people have a heart attack, and about 1 in 20 adults aged 20 and older has coronary artery disease (about 5%). Access the Global Ultrasound Devices and Accessories Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Ultrasound Transducer Market Insights The global ultrasound transducer market size was valued at USD 3.3 billion in 2022 and is expected to expand at a CAGR of 4.8% from 2023 to 2030. It is expected to expand at a CAGR of 3.6% during the forecast period. Increasing number of product launches and growing focus of the major players on innovations for safe and accurate diagnosis are the factors driving the growth. North America is anticipated to hold substantial share of the market during the forecast period owing to high adoption of advanced medical devices. Continuous innovations in ultrasound machine such as portable and mobile ultrasound machine is expected to fuel the growth. Moreover, presence of a large number of ultrasound transducer manufacturers is anticipated to bode well for the regional growth. These companies emphasize on heavy investments to develop smart production methods and process automation, which is a key factor in optimizing product prices and maximizing revenues. Another innovation pertaining to these devices include burst wave lithotripsy which help delicate procedures including kidney stone destruction. The technology is not only efficient but also offers non-invasive procedure to patients, which is anticipated to ultimately augment the product demand in the forthcoming years. Growing number of partnerships between resellers for ultrasound transducers is an emerging trend witnessed in the market. Direct purchase from Original Equipment Manufacturers (OEMs) is another trend observed in the market. End users are increasingly dealing with OEMs since they offer efficient technologies like custom strain gauge sensing to finished product designs, to achieve greater business advantage. Ultrasound Gels Market insights The global ultrasound gel market size was valued at USD 101.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 2.6% from 2023 to 2030. The increasing adoption rate of ultrasound devices in healthcare settings due to its diagnostic efficiency and cost-effectiveness is the factor expected to drive the demand for the conductive medium during the forecast period. In addition, the increasing number of external sonography procedures requiring a low level of sterility has contributed to its largest market share. Increasing patient visits reporting problems such as heart disease, kidney and gallbladder problems, and lung and intestinal diseases where ultrasound primarily finds application is expected to increase the consumption rate of the gel. Growing concern to protect the ultrasound transducer from damages and the developing trend to provide utmost patient satisfaction during treatment has led to increasing demand for odorless, colorless, and stain-free ultrasound gels. The availability of handheld sonography devices at affordable prices has promoted their adoption rate in small-sized clinics. Therefore, the growing installation rate of sonography units in clinics has contributed to the rising demand of gel in these setups. Availability of alternative to ultrasound gels, the advent of gel-free sonography probes, and limited access to medical consumables in rural areas are expected to resist the growth of the market during the forecast period. The gel-free sonography probes can be a major threat to the market, but its expensiveness is limiting its adoption rate. Order your copy of the Free Sample of “Ultrasound Devices and Accessories Industry Data Book - Ultrasound Device, Ultrasound Transducer and Ultrasound Gels Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Ultrasound Devices and Accessories Industry Data Book Competitive Landscape The major players are working to improve their product offerings by upgrading their products, taking advantage of important cooperation activities, and exploring acquisitions and government clearances in order to expand their customer base and gain a larger share of the overall market. Key players operating in the ultrasound devices and accessories industry are – • Compass Health Brands • ECO-MED • National Therapy Products • H.R Pharmaceuticals Inc • Tele-Paper Malaysia • Sonogel Vertriebs • Medline Industries, Inc • Parker Laboratories • Ultragel Kft. Patient Monitoring Devices Industry Emerging Trends, Technologies And Revolutionizing Healthcare11/22/2023 |
Archives
December 2023
Categories |